How factor VIIa works in hemophilia

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 6, 2003, Pages 1158-1160

  Butenas, S ^a   Brummel, K E ^a   Bouchard, B A ^a   Mann, K G ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Factor VIIa; Hemophilia; Platelets; Thrombin generation

Indexed keywords

BLOOD CLOTTING FACTOR 7; RECOMBINANT FVIIA; RECOMBINANT PROTEIN; THROMBIN; THROMBOPLASTIN;

ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; HEMOPHILIA B; HEMOSTASIS; HUMAN; KINETICS; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE COUNT;

BLOOD PLATELETS; CELLS, CULTURED; FACTOR VII; HEMOPHILIA B; HEMOSTASIS; HUMANS; KINETICS; MODELS, BIOLOGICAL; PLATELET COUNT; RECOMBINANT PROTEINS; THROMBIN; THROMBOPLASTIN;

EID: 0042488294     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00181.x     Document Type: Article

References (17)

1. Nilsson IM, Berntorp I, Zettervall O. Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies. Proc Natl Acad Sci USA 1986; 83: 9169-73.
2. Nuss R, Jacobson L, Hathaway WE, Manco-Johnson M. Evidence for antiphospholipid antibodies in hemophilic children with factor VIII inhibitors. Recombinate PUP Study Group. Thromb Haemost 1999; 82: 1559-60.
3. Hedner U. Recombinant factor VIIa (NovoSeven) as a hemostatic agent. Semin Hematol 2001; 38 (Suppl. 12): 43-7.
4. Santagostino A, Morfini M, Rocino A, Baudo F, Scaraggi FA, Gringeri A. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors. Thromb Haemost 2001; 86: 954-8.
5. Smith MP, Ludlam CA, Collins PW, Hay SRM, Wilde JT, Grigeri A, Melsen T, Savidge GF. Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII. Thromb Haemost 2001; 86: 949-53.
6. Henderson N, Key NS, Christie B, Kisiel W, Foster D, Nelsestuen GL. Response of factor VIII and IX-deficient blood to wild type and high membrane affinity mutant factor VIIa in an in vitro whole blood clotting assay: possible correlation to clinical outcome. Thromb Haemost 2002; 88: 98-103.
7. Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG. Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 2002; 99: 923-30.
8. Butenas S, Brummel KE, Paradis SG, Mann KG. Influence of factor VIIa and phospholipids on coagulation in 'acquired' hemophilia. Arterioscler Thromb Vasc Biol 2003; 23: 123-9.
9. van't Veer C, Golden NJ, Mann KG. Inhibition of thrombin generation by the zymogen factor VII. implications for the treatment of hemophilia A by factor VIIa. Blood 2000; 95: 1330-5.
10. Bajaj SP, Rapaport SI, Prodanos C. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 1981; 11: 397-412.
11. Katzmann JA, Nesheim ME, Hibbard LS, Mann KG. Isolation of functional human coagulation factor V by using a hybridoma antibody. Proc Natl Acad Sci USA 1981; 78: 162-6.
12. Griffith MJ, Noyes CM, Church FC. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. J Biol Chem 1985; 260: 2218-25.
13. van't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem 1997; 272: 4367-77.
14. Cawthern KM, van't Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood 1998; 91: 4581-92.
15. Mustard JF,Perry DW,Ardlie NG,Packham MA. Preparation of suspension of washed platelets from humans. Br J Haematol 1972; 22: 193-204.
16. Rand MD, Lock JB, van't Veer C, Gaffney DP, Mann KG. Blood clotting in minimally altered whole blood. Blood 1996; 88: 3432-45.
17. Lawson JH, Kalafatis M, Stram S, Mann KG. A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem 1994; 269: 23357-66.